{"id": 815285, "name": "Statin use", "unit": "DDD (defined daily doses) per 1000 population", "createdAt": "2023-10-10T15:55:32.000Z", "updatedAt": "2024-10-07T20:15:32.000Z", "coverage": "", "timespan": "2019-2020", "datasetId": 6265, "shortUnit": "", "columnOrder": 0, "shortName": "statin_use", "catalogPath": "grapher/statins/2023-10-05/bmj_2022/bmj_2022#statin_use", "descriptionShort": "Based on purchases made by stores and hospitals in 52 countries and, in special cases like the UK, using data about the volume given to patients.", "descriptionProcessing": "The 2019 data addresses evaluations of statin utilization estimates from October 2019 to March 2020, while the 2020 data pertains to assessments conducted from April 2020 to October 2020.", "type": "float", "dataChecksum": "9112845417468118514", "metadataChecksum": "4156561174629726378", "datasetName": "Global, regional and national trends in statin utilisation in high-income and low/middle-income countries, 2015-2020.", "datasetVersion": "2023-10-05", "nonRedistributable": false, "display": {"unit": "DDD (defined daily doses) per 1000 population", "numDecimalPlaces": 1}, "schemaVersion": 2, "processingLevel": "minor", "presentation": {"topicTagsLinks": ["Cardiovascular Diseases"], "faqs": []}, "descriptionKey": [], "dimensions": {"years": {"values": [{"id": 2019}, {"id": 2020}]}, "entities": {"values": [{"id": 17, "name": "Algeria", "code": "DZA"}, {"id": 21, "name": "Argentina", "code": "ARG"}, {"id": 23, "name": "Australia", "code": "AUS"}, {"id": 24, "name": "Austria", "code": "AUT"}, {"id": 28, "name": "Bangladesh", "code": "BGD"}, {"id": 30, "name": "Belarus", "code": "BLR"}, {"id": 4, "name": "Belgium", "code": "BEL"}, {"id": 37, "name": "Brazil", "code": "BRA"}, {"id": 39, "name": "Bulgaria", "code": "BGR"}, {"id": 44, "name": "Canada", "code": "CAN"}, {"id": 172, "name": "Chile", "code": "CHL"}, {"id": 171, "name": "China", "code": "CHN"}, {"id": 170, "name": "Colombia", "code": "COL"}, {"id": 165, "name": "Croatia", "code": "HRV"}, {"id": 162, "name": "Czechia", "code": "CZE"}, {"id": 161, "name": "Denmark", "code": "DNK"}, {"id": 160, "name": "Dominican Republic", "code": "DOM"}, {"id": 201, "name": "Ecuador", "code": "ECU"}, {"id": 65, "name": "Egypt", "code": "EGY"}, {"id": 156, "name": "Estonia", "code": "EST"}, {"id": 155, "name": "Finland", "code": "FIN"}, {"id": 3, "name": "France", "code": "FRA"}, {"id": 6, "name": "Germany", "code": "DEU"}, {"id": 149, "name": "Greece", "code": "GRC"}, {"id": 138, "name": "Hungary", "code": "HUN"}, {"id": 137, "name": "India", "code": "IND"}, {"id": 136, "name": "Indonesia", "code": "IDN"}, {"id": 2, "name": "Ireland", "code": "IRL"}, {"id": 8, "name": "Italy", "code": "ITA"}, {"id": 14, "name": "Japan", "code": "JPN"}, {"id": 130, "name": "Jordan", "code": "JOR"}, {"id": 131, "name": "Kazakhstan", "code": "KAZ"}, {"id": 122, "name": "Latvia", "code": "LVA"}, {"id": 124, "name": "Lebanon", "code": "LBN"}, {"id": 119, "name": "Lithuania", "code": "LTU"}, {"id": 210, "name": "Luxembourg", "code": "LUX"}, {"id": 116, "name": "Malaysia", "code": "MYS"}, {"id": 113, "name": "Mexico", "code": "MEX"}, {"id": 110, "name": "Morocco", "code": "MAR"}, {"id": 5, "name": "Netherlands", "code": "NLD"}, {"id": 106, "name": "New Zealand", "code": "NZL"}, {"id": 102, "name": "Norway", "code": "NOR"}, {"id": 101, "name": "Pakistan", "code": "PAK"}, {"id": 97, "name": "Peru", "code": "PER"}, {"id": 96, "name": "Philippines", "code": "PHL"}, {"id": 11, "name": "Poland", "code": "POL"}, {"id": 95, "name": "Portugal", "code": "PRT"}, {"id": 92, "name": "Romania", "code": "ROU"}, {"id": 12, "name": "Russia", "code": "RUS"}, {"id": 88, "name": "Serbia", "code": "SRB"}, {"id": 86, "name": "Singapore", "code": "SGP"}, {"id": 85, "name": "Slovakia", "code": "SVK"}, {"id": 83, "name": "Slovenia", "code": "SVN"}, {"id": 81, "name": "South Africa", "code": "ZAF"}, {"id": 127, "name": "South Korea", "code": "KOR"}, {"id": 9, "name": "Spain", "code": "ESP"}, {"id": 141, "name": "Sri Lanka", "code": "LKA"}, {"id": 10, "name": "Sweden", "code": "SWE"}, {"id": 7, "name": "Switzerland", "code": "CHE"}, {"id": 198, "name": "Taiwan", "code": "TWN"}, {"id": 75, "name": "Thailand", "code": "THA"}, {"id": 71, "name": "Tunisia", "code": "TUN"}, {"id": 70, "name": "Turkey", "code": "TUR"}, {"id": 67, "name": "Ukraine", "code": "UKR"}, {"id": 72, "name": "United Arab Emirates", "code": "ARE"}, {"id": 1, "name": "United Kingdom", "code": "GBR"}, {"id": 13, "name": "United States", "code": "USA"}, {"id": 63, "name": "Uruguay", "code": "URY"}, {"id": 238, "name": "Venezuela", "code": "VEN"}, {"id": 84, "name": "Vietnam", "code": "VNM"}]}}, "origins": [{"id": 1453, "titleSnapshot": "Global, regional and national trends in statin utilisation  (Guadamuz , Shooshtari and Qato, 2022)", "title": "Global, regional and national trends in statin utilisation in high-income and low/middle-income countries, 2015-2020.", "descriptionSnapshot": "This dataset and study focus on investigating the global utilization of statins, which are essential medicines for cardiovascular disease (CVD) prevention, and exploring the disparities and trends in their use across various income groups, regions, and countries from 2015 to 2020.\n\nKey Points:\n- Data Source: Pharmaceutical sales data.\n- Countries Included: 41 HICs and 50 LMICs.\n- Population aged 40 years and above.\n- Primary and Secondary Outcome Measures: Statin utilization, measured using defined daily doses (DDDs) per 1000 population \u226540 years per day (TPD).", "producer": "Guadamuz, Shooshtari and Qato", "citationFull": "Guadamuz JS, Shooshtari A, Qato DM. Global, regional and national trends in statin utilisation in high-income and low/middle-income countries, 2015-2020.", "urlMain": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462115/", "urlDownload": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462115/bin/bmjopen-2022-061350supp001.pdf", "dateAccessed": "2023-10-05", "datePublished": "2022-09-22", "license": {"name": "CC BY 4.0"}}]}